Bharat Biotech’s Nucelion to Manufacture Pandorum’s Designer-Exosome Eye Therapies Under PRIP-Backed Projects

Nucelion Therapeutics, the cell and gene therapy CDMO arm of Bharat Biotech, will provide process development and GMP manufacturing support for two Pandorum Technologies ophthalmology programmes in advanced keratopathy and wet AMD, with a combined outlay of ₹16.97 crore including up to ₹8 crore under the Centre’s PRIP scheme.